Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

INK4a/ARF: a multifunctional tumor suppressor locus.

Norman E Sharpless1

  • 1Department of Medicine, The Lineberger Comprehensive Cancer Center, The University of North Carolina School of Medicine, Chapel Hill, 27599-7295, USA. nes@med.unc.edu

Mutation Research
|May 10, 2005
PubMed
Summary

Both p16INK4a and ARF are crucial tumor suppressors regulating cell pathways. Genetic data confirms their in vivo activity, with roles varying by species and cell type in cancer prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Threat to Evidence-Based Vaccine Policy and Public Health Security at the FDA.

The New England journal of medicine·2025
Same author

Epidermal growth factor receptor and Ink4a/Arf: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis.

Cancer cell·2024
Same author

Bridging the Gap in Cancer Clinical Trial Funding.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Expression of Concern: Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma.

Cancer discovery·2024
Same author

Author Correction: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.

Nature medicine·2024
Same author

The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The INK4a/ARF locus produces two tumor suppressor proteins: p16INK4a (regulating RB pathway) and ARF (regulating p53 pathway).
  • Initial research questioned if both proteins were true tumor suppressors due to their linked genomic location.

Purpose of the Study:

  • To review the evolutionary history of the INK4a/ARF locus.
  • To discuss the established tumor suppressor roles of p16INK4a and ARF in human cancer.
  • To explore novel functions of these proteins.

Main Methods:

  • Review of human and mouse genetic data.
  • Analysis of species- and cell-type specific differences in tumor suppressor activity.
  • Discussion of evolutionary and biochemical data.

Related Experiment Videos

Main Results:

  • Both p16INK4a and ARF exhibit significant in vivo tumor suppressor activity.
  • ARF is critical in preventing Myc-induced lymphomagenesis in mice.
  • p16INK4a's role is more established in human carcinomas.

Conclusions:

  • Both p16INK4a and ARF are vital tumor suppressors with distinct roles.
  • Understanding their functions is crucial for cancer research and therapy.
  • Further research into novel functions may reveal new therapeutic targets.